Cover Image
Market Research Report
Product code 
1001437

Europe Cell Line Development Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Type, Product, Application

Published: | The Insight Partners | 114 Pages | Delivery time: 1-2 business days

Price

Back to Top
Europe Cell Line Development Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Type, Product, Application
Published: March 17, 2021
The Insight Partners
Content info: 114 Pages
Delivery time: 1-2 business days
  • ALL
  • Description
  • Table of Contents
Description

The Europe cell line development market is expected to reach US$ 3,187.57million in 2027 from US$ 1,214.01million in 2019. The market is estimated to grow with a CAGR of 13.0% from 2020-2027.

The market growth is primariliy driven by the increasing government participation in the cell line development prohjects and an upsurge in the development of the biotechnology industry. However, the susceptibility of cell lines toward contamination by various microorganisms hinders the market growth.

Government organizations have in Europe have been contributing to the growth of the Europe cell line development market. For instance, the Medical Research Council (MRC) and Biotechnology and Biological Sciences Research Council (BBSRC) funds the UK Stem Cell Bank, which was established in 2002. The bank stores characterize and supply ethically approved, quality-controlled stem cell lines for medical research and treatment. They majorly focus on human embryonic stem cell lines (hESC). According to the OECD statistics, ~US$ 1,186 million is spent on biotechnology research in the UK that accounts for the fourth highest expenditure on research, after the US, France, and Switzerland.

Moreover, government participation in stem cell research is also one of the significant factors for cell line development growth. The National Bank of Cell Lines (Banco Nacional de Lineas Celulares, BNLC) is a network organized by the Instituto de Salud Carlos III (ISCIII), based in Madrid. The BNCL is a non-profit organization and follows the ethical principles established in international treaties related to biomedical research and human rights. The organization preserves and supplies human stem cells, either embryonic or adult, for biomedical investigations.

As the novel coronavirus and the disease it causes (COVID-19) has spread worldwide, it has created profound disruption across communities, patients, and clinicians. Pharmaceutical and MedTech companies are engaged in developing new therapeutics and vaccines against COVID-19. Simultaneously, clinical and product developments related to other therapeutics has experienced disruption due to the implementation of remote operations and availability of reduced workforce on the work floors at a time. Moreover, the pharmaceutical companies have been prioritizing research and development activities related to COVID-19, encompassing diagnostics, treatments, health technologies, and vaccines. AstraZeneca collaborated with the University of Oxford to develop and distribute the potential recombinant adenovirus vaccine preventing COVID-19 infection. Also, the ongoing clinical trials have been put on hold due to the COVID-19 crisis. In the UK, the National Institute for Health Research (NIHR) supports the infrastructure for developing and running clinical trials in England. In 2019, the NIHR funded over 6,100 clinical studies for cancer research. However, in early 2020, in response to the challenges presented by the COVID-19 crisis, the NIHR announced the suspension of clinical trials to propritize the development of new COVID-19 studies. These changes in conditions have been hindering the growth of the cell line development market in Europe.

On the basis of type, the North America cell line development market is segmented into primary cell lines, hybridomas, continuous cell lines, and recombinant cell lines. The recombinant cell line segments held the largest market share in 2019, whereas the hybridomas segment is anticipated to register the highest CAGR in the market during the forecast period. The North America cell line development market, by product, is segmented into equipment, and media and reagents. The media & reagent segment held a larger share of the market in 2019, and it is anticipated to register a higher CAGR in the market from 2020 to 2027. Based on application, the North America cell line development market is segmented into drug discovery, bioproduction, and tissue engineering. The bioproduction segment held the largest market share in 2019. However, the drug discovery segment is anticipated to register the highest CAGR in the market during 2020-2027.

UK Stem Cell Foundation, European Forum for Industrial Biotechnology and the Bioeconomy (EFIB), and Biotechnology and Biological Sciences Research Council (BBSRC) are a few of the primary and secondary sources referred to while preparing the report on the Europe cell line development market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the cell line development market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the Europe cell line development market market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table of Contents
Product Code: TIPRE00009032

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Cell line development Market - By Type
    • 1.3.2 Cell line development Market - By Product
    • 1.3.3 Cell line development Market - By Application
    • 1.3.4 EuropeCell line development Market - By Country

2. Europe Cell Line Development Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. EuropeCell Line Development Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 Cell Line Development Market- Europe PEST Analysis
  • 4.3 Expert Opinion

5. Europe Cell Line Development Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increasing Government Participation in the Cell Line Development Market
    • 5.1.2 An Upsurge in the Development of the Biotechnology Industry
  • 5.2 Market Restraints
    • 5.2.1 Contamination of Cell Line by Microorganisms
  • 5.3 Market Opportunity
    • 5.3.1 Increasing Technological Advancements Regarding Cell Line Development
  • 5.4 Future Trend
    • 5.4.1 Growing Development of Innovative Products in the Cell Line Development Market
  • 5.5 Impact Analysis

6. Cell Line Development Market - Europe Analysis

  • 6.1 EuropeCell Line Development Market Revenue Forecasts and Analysis

7. EuropeCell Line Development Market Analysis and Forecasts To 2027 - ByType

  • 7.1 Overview
  • 7.2 Cell Line Development Market, by Type, 2019& 2027 (% Share)
  • 7.3 Primary Cell Line
    • 7.3.1 Overview
    • 7.3.2 Primary Cell Line Market Revenue and Forecast to 2027 (US$ Mn)
  • 7.4 Hybridomas
    • 7.4.1 Overview
    • 7.4.2 Hybridomas Market Revenue and Forecast to 2027 (US$ Mn)
  • 7.5 Continuous Cell Lines
    • 7.5.1 Overview
    • 7.5.2 Continuous Cell Lines Market Revenue and Forecast to 2027 (US$ Mn)
  • 7.6 Recombinant Cell Line
    • 7.6.1 Overview
    • 7.6.2 Recombinant Cell Line Market Revenue and Forecast to 2027 (US$ Mn)

8. Europe Cell Line Development Market Analysis and Forecasts To 2027 - ByProduct

  • 8.1 Overview
  • 8.2 Cell Line Development Market, by Product, 2019& 2027 (% Share)
  • 8.3 Equipment
    • 8.3.1 Overview
    • 8.3.2 Equipment Market Revenue and Forecast to 2027 (US$ Mn)
  • 8.4 Media and Reagent
    • 8.4.1 Overview
    • 8.4.2 Media and Reagent Market Revenue and Forecast to 2027 (US$ Mn)

9. Europe Cell Line Development Market Analysis - ByApplication

  • 9.1 Overview
  • 9.2 Cell Line Development Market Share by Application 2019& 2027 (%)
  • 9.3 Drug Discovery
    • 9.3.1 Overview
    • 9.3.2 Drug Discovery Market Revenue and Forecast to 2027 (US$ Mn)
  • 9.4 Bioproduction
    • 9.4.1 Overview
    • 9.4.2 Bioproduction Market Revenue and Forecast to 2027 (US$ Mn)
  • 9.5 Tissue Engineering
    • 9.5.1 Overview
    • 9.5.2 Tissue Engineering Market Revenue and Forecast to 2027 (US$ Mn)

10. Cell Line Development Market Revenue and Forecasts To 2027 - Geographical Analysis

  • 10.1 Europe Cell Line Development Market Revenue and Forecast to 2027
    • 10.1.1 Europe Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
    • 10.1.2 Europe Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
    • 10.1.3 Europe Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
    • 10.1.4 Europe Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
    • 10.1.5 Europe Cell Line Development Market, Revenue and Forecast to 2027, By Country (%)
    • 10.1.6 Germany
      • 10.1.6.1 Germany Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
      • 10.1.6.2 Germany Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
      • 10.1.6.3 Germany Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
      • 10.1.6.4 Germany Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
    • 10.1.7 UK
      • 10.1.7.1 UK Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
      • 10.1.7.2 UK Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
      • 10.1.7.3 UK Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
      • 10.1.7.4 UK Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
    • 10.1.8 France
      • 10.1.8.1 France Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
      • 10.1.8.2 France Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
      • 10.1.8.3 France Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
      • 10.1.8.4 France Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
    • 10.1.9 Spain
      • 10.1.9.1 Spain Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
      • 10.1.9.2 Spain Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
      • 10.1.9.3 Spain Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
      • 10.1.9.4 Spain Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
    • 10.1.10 Italy
      • 10.1.10.1 Italy Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
      • 10.1.10.2 Italy Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
      • 10.1.10.3 Italy Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
      • 10.1.10.4 Italy Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)

11. Impact of COVID-19 Pandemic on EuropeCell Line Development Market

  • 11.1 Europe: Impact Assessment of COVID-19 Pandemic

12. Company Profiles

  • 12.1 Merck KGaA
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Financial Overview
    • 12.1.4 Product Portfolio
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Thermo Fisher Scientific, Inc.
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Financial Information
    • 12.2.4 Product /Services Portfolio
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 SELEXIS
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Financial Overview
    • 12.3.4 Product/Service Portfolio
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 WuXi AppTec
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Financial Overview
    • 12.4.4 Service Portfolio
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 General Electric
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Financial Overview
    • 12.5.4 Product Portfolio
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Lonza
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Financial Information
    • 12.6.4 Product Portfolio
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Corning Incorporated
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Financial Overview
    • 12.7.4 Product Portfolio
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments

13. Appendix

  • 13.1 About the Insight Partners
  • 13.2 Glossary of terms

List Of Tables

  • Table 1. Europe Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
  • Table 2. Europe Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
  • Table 3. Europe Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
  • Table 4. Germany Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
  • Table 5. Germany Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
  • Table 6. Germany Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
  • Table 7. UK Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
  • Table 8. UK Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
  • Table 9. UK Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
  • Table 10. France Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
  • Table 11. France Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
  • Table 12. France Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
  • Table 13. Spain Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
  • Table 14. Spain Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
  • Table 15. Spain Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
  • Table 16. Italy Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
  • Table 17. Italy Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
  • Table 18. Italy Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
  • Table 19. Glossary of Terms, Cell Line Development Market

List Of Figures

  • Figure 1. Cell Line DevelopmentMarket Segmentation
  • Figure 2. EuropeCell Line Development Market Overview
  • Figure 3. Recombinant Cell Line Segment Held Largest Share of Typein Cell Line DevelopmentMarket
  • Figure 4. Germany is Expected to Show Remarkable Growth During the Forecast Period
  • Figure 5. Cell Line Development Market - Europe PEST Analysis
  • Figure 6. Cell Line Development Market Impact Analysis of Driver and Restraints
  • Figure 7. EuropeCell Line Development Market - Revenue Forecasts and Analysis - 2019- 2027
  • Figure 8. Cell Line Development Market, Type, 2019& 2027 (% Share)
  • Figure 9. Primary Cell Line Market Revenue and Forecast to 2027 (US$ Mn)
  • Figure 10. Hybridomas Market Revenue and Forecast to 2027 (US$ Mn)
  • Figure 11. Continuous Cell Lines Market Revenue and Forecast to 2027 (US$ Mn)
  • Figure 12. Recombinant Cell Line Market Revenue and Forecast to 2027 (US$ Mn)
  • Figure 13. Cell Line Development Market, By Product, 2019& 2027 (% Share)
  • Figure 14. Equipment Market Revenue and Forecast to 2027 (US$ Mn)
  • Figure 15. Media and ReagentMarket Revenue and Forecast to 2027 (US$ Mn)
  • Figure 16. Cell Line Development Market Share by Application 2019& 2027 (%)
  • Figure 17. Drug Discovery Market Revenue and Forecast to 2027 (US$ Mn)
  • Figure 18. Bioproduction Market Revenue and Forecast to 2027 (US$ Mn)
  • Figure 19. Tissue Engineering Market Revenue and Forecast to 2027 (US$ Mn)
  • Figure 20. Europe Cell Line Development Market Revenue, By Country, 2019 (US$ Mn)
  • Figure 21. Europe Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
  • Figure 22. Europe Cell Line Development Market, Revenue and Forecast to 2027, By Country (%)
  • Figure 23. Germany Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
  • Figure 24. UK Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
  • Figure 25. France Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
  • Figure 26. Spain Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
  • Figure 27. Italy Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
  • Figure 28. Impact of COVID-19 Pandemic in Europe Country Markets